Literature DB >> 14718423

Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD.

George Chrysofakis1, Nikolaos Tzanakis, Despina Kyriakoy, Maria Tsoumakidou, Ioanna Tsiligianni, Maria Klimathianaki, Nikolaos M Siafakas.   

Abstract

BACKGROUND: Previous studies have shown that the inflammatory response to cigarette smoking differs between smokers who acquire COPD and those who do not, and the CD8(+) T- lymphocytes have been identified as a key player in this response.
OBJECTIVE: To investigate the cytotoxic activity and perforin expression of CD8(+) lymphocytes in the airway lumen of patients with COPD.
METHODS: Thirty-six male smokers with COPD, 25 male smokers without COPD, and 10 healthy nonsmokers participated in the study. T-lymphocytes of induced sputum samples were labeled with appropriate monoclonal antibodies and measured using flow cytometry. The cytotoxic activity of CD8(+) cells was defined by incubating them with specific target cells (K562).
RESULTS: The percentage and the total number of CD8(+) lymphocytes were significantly higher in COPD smokers compared to non-COPD smokers (p = 0.01 and p = 0.005, respectively) or to healthy nonsmokers (p = 0.02 and p = 0.01, respectively). Perforin expression in CD8(+) cells was significantly higher in smokers with COPD compared to the other two groups (p = 0.001). Increased cytotoxic activity of T cells was also observed in induced sputum of patients with COPD in comparison to the other two groups.
CONCLUSION: CD8(+) cells are not only increased in number in sputum samples of smokers with COPD but are highly activated, expressing high levels of perforin. These findings suggest that CD8(+) T-lymphocytes play a significant role in the inflammatory process of COPD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718423     DOI: 10.1378/chest.125.1.71

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  42 in total

1.  A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity.

Authors:  M W Lethbridge; D M Kemeny; J C Ratoff; B J O'Connor; C M Hawrylowicz; C J Corrigan
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 2.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

3.  Proinflammatory and prothrombotic status in emphysematous rats exposed to intermittent hypoxia.

Authors:  Caili Li; Xiaokun Yang; Jing Feng; Ping Lei; Yubao Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 4.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 5.  Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know.

Authors:  Mathieu C Morissette; Julie Parent; Julie Milot
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

6.  Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers.

Authors:  Izolde Bouloukaki; Maria Tsoumakidou; Constantine I Vardavas; Ioanna Mitrouska; Eleni Koutala; Nikolaos M Siafakas; Sophia E Schiza; Nikos Tzanakis
Journal:  Mediators Inflamm       Date:  2010-02-23       Impact factor: 4.711

7.  Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2010-06-11

8.  Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.

Authors:  Ester Roos-Engstrand; Jamshid Pourazar; Annelie F Behndig; Anders Blomberg; Anders Bucht
Journal:  Respir Res       Date:  2010-09-24

Review 9.  Apoptotic mechanisms in the pathogenesis of COPD.

Authors:  Maria Plataki; Eleni Tzortzaki; Paula Rytila; Makris Demosthenes; Anastassios Koutsopoulos; Nikolaos M Siafakas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Altered effector function of peripheral cytotoxic cells in COPD.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2009-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.